Autoimmune Conditions and Peptide Therapy LIVV Natural FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA moves toward easing restrictions on certain peptides BioPharma Dive The Peptide Craze Ground Truths